Kratom-Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review

被引:108
作者
Eastlack, Steven C. [1 ]
Cornett, Elyse M. [2 ]
Kaye, Alan D. [3 ,4 ,5 ]
机构
[1] LSU Hlth Sci Ctr, Sch Med, 1901 Perdido St, New Orleans, LA 70112 USA
[2] LSU Hlth Shreveport, Dept Anesthesiol, 1501 Kings Highway, Shreveport, LA 71103 USA
[3] Louisiana State Univ, Sch Med, Dept Anesthesiol, 1501 Kings Hwy, Shreveport, LA 71103 USA
[4] Louisiana State Univ, Sch Med, Dept Pharmacol Toxicol & Neurosci, 1501 Kings Hwy, Shreveport, LA 71103 USA
[5] Tulane Sch Med, New Orleans, LA 70112 USA
关键词
Drug abuse; Drug addiction; Kratom; Mitragynine; Opioid; Stimulant; MITRAGYNA-SPECIOSA KORTH; THAI HERBAL MEDICINE; IN-VITRO; ANTINOCICEPTIVE TOLERANCE; WITHDRAWAL SYMPTOMS; SALVIA-DIVINORUM; ALKALOID EXTRACT; OPIOID RECEPTORS; 7-HYDROXYMITRAGYNINE; ABUSE;
D O I
10.1007/s40122-020-00151-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Kratom, or Mitragyna, is a tropical plant indigenous to Southeast Asia, with unique pharmacological properties. It is commonly consumed by preparing the leaves into decoction or tea, or by grinding them into a powder. Recent evidence has revealed that kratom has physiological effects similar to opioids, including pain relief and euphoria, as well as stimulant properties, which together raise potential concern for dependence and addiction. Moreover, growing evidence suggests that the prevalence of kratom use is increasing in many parts of the world, raising important considerations for healthcare providers. This manuscript will discuss the most current epidemiology, pharmacology, toxicity, and management related to kratom, while seeking to provide a contemporary perspective on the issue and its role in the greater context of the opioid epidemic.
引用
收藏
页码:55 / 69
页数:15
相关论文
共 131 条
  • [1] Cardiac arrest in a young healthy male patient secondary to kratom ingestion: is this 'legal high' substance more dangerous than initially thought ?
    Abdullah, Hafez Mohammad Ammar
    Haq, Iqra
    Lamfers, Randall
    [J]. BMJ CASE REPORTS, 2019, 12 (07)
  • [2] Adkins JE, 2011, CURR TOP MED CHEM, V11, P1165
  • [3] Outpatient buprenorphine induction and maintenance treatment for kratom dependence: A case study
    Agapoff, James R.
    Kilaru, Usha
    [J]. JOURNAL OF SUBSTANCE USE, 2019, 24 (06) : 575 - 577
  • [4] [Anonymous], 2019, GUIDE KRATOM LEGALIT
  • [5] [Anonymous], 2019, BULL ENVIRON PHARMAC
  • [6] Herb-Induced Liver Injury With Cholestasis and Renal Injury Secondary to Short-Term Use of Kratom (Mitragyna speciosa)
    Antony, Andrew
    Lee, Tai-Ping
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (04) : E546 - E547
  • [7] Anwar R., 2012, PHARMACOLOGYONLINE, V1, P68
  • [8] Kratom alkaloids and O-desmethyltramadol in urine of a "Krypton" herbal mixture consumer
    Arndt, Torsten
    Claussen, Ulrich
    Guessregen, Brunhilde
    Schroefel, Stefanie
    Stuerzer, Birgit
    Werle, Annika
    Wolf, Gerald
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2011, 208 (1-3) : 47 - 52
  • [9] The use of Mitragynine speciosa ("Krathom"), an addictive plant, in Thailand
    Assanangkornchai, Sawitri
    Muekthong, Anocha
    Sam-Angsri, Nisan
    Pattanasattayawong, Uriwan
    [J]. SUBSTANCE USE & MISUSE, 2007, 42 (14) : 2145 - 2157
  • [10] Azizi Juzaili, 2013, Drug Metabolism and Drug Interactions, V28, P95, DOI 10.1515/dmdi-2012-0039